4^th World Conference on Breast and Cervical Cancer November 14-15, 2019 Amsterdam, Netherlands

Track 1: Breast Cancer Biology

Breast cancer starts when cells in the breast begin to grow abnormally. These cells frequently form a tumor that can often be seen on an x-ray or felt a lump. Breast Cancer occurs mostly in women, but very rare chances to get in men. This starts from different parts of the breast. Most breast cancers begin in the duck carry milk to the nipple. Many of the breast cancer form lumps, but not all do. Most of the lumps are begin and not cancer (malignant). Non-cancerous breast tumors are irregular developments, but they do not spread outside of the breast and they are not life-threatening. Investigating the difficulties regarding brilliance in Breast Cancer Conferences, Oncology Meetings research and investigation which incorporates provoke keynote introductions, Oral talks, Poster introductions, and Exhibitions.

Track 2: Cervical Cancer Biology

The Cervix is the lower some portion of the uterus which opens into the vagina. At the point when the strange cells of the cervix become crazy, cervical disease happens. Cervical growth can be effectively known in the beginning of periods by a test called 'Pap test'. Most sorts of cervical disease are caused by an infection known as Human Papillomavirus or HPV. There are many kinds of HPV. However, every kind does not bring about cervical tumor. A few causes genital warts which do not have any side effects. The main approaches of cervical growth are smoking, use of oral preventative pills and getting numerous pregnancies. The side effects of cervical malignancy incorporate unpredictable seeping from the vagina other than the conclusive time traverse of general menstrual cycle, torment in the lower stomach area, torment amid sexual relations and irregular vaginal release. Each sort of cervical malignancy isn't lethal to the ladies. Treatment that incorporates surgeries and chemotherapies has been turned out to be fruitful in treating cervical malignancy in the underlying stages.

Track 3: Cancer Genomics

Genes are instructions which tell the body how to make all the proteins it needs to continue and produce. Cancer genomics is the study of the whole DNA arrangement and quality articulation contrasts between tumour cells and typical host cells. It expects to comprehend the genetic premise of tumour cell growth and the development of the growth genome under change and determination by the body condition, the immune system and therapeutic interventions.

In cancer cells, little variations in the genetic letters can change what a genomic word or sentence implies. A transformed letter can make the cell make a protein that doesn't enable the cell to fill in as it should. These proteins can influence cells to develop rapidly and make harm neighbouring cells. By concentrate the growth genome, researchers can find what letter changes are making a cell turn into a disease. The genome of a tumour cell can likewise be utilized to disclose to one kind of disease from another. Now and again, examining the genome in a growth can help recognize a subtype of malignancy inside that write, for example, HER2+ breast tumour. Understanding the tumour genome may likewise enable a specialist to choose the best treatment for every patient.

Track 4: Immunological Approaches to Cancer Therapy

Cancer immunotherapy (also called immuno-oncology) is the application of the safe outline to regard cancer. Immunotherapies can be divided as dynamic, inactive or mixture (dynamic and detached). These procedures abuse the way that growing cells regularly have elements on their surface that can be distinguished by the safe framework, known as tumor-associated antigens (TAAs); they are frequently proteins or different macromolecules (e.g. starches). Dynamic immunotherapy guides the safe agenda to attack tumor cells by focusing on TAAs. Uninvolved immunotherapies improve existing hostile to tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes, and cytokines.

The immune-system efficiently prevents cancer, though life-threatening immune-depression expands its rate. Malignancy immune-prevention is a technique in view of the idea that advancement of tumor insusceptibility in sound people reduces growth to chance. It is a sort of chemoprevention. For growth immune-prevention, the malignancy universe can be conveniently separated between tumors caused - specifically or in a roundabout way - by irresistible operators and every other tumor. Immuno-prevention of tumors produced by appealing operators is as of now implemented at the populace level for hepatitis B infection (HBV); related hepatocellular carcinoma and for tumors caused by human papillomaviruses (HPV), like cervical carcinoma. Now the test is to create immunological measures to retain the mass (>80%) of human tumor load, irrelevant to diseases.

Track 5: Breast and Cervical Cancer Screening

Cancer among women is a noteworthy general medical issue in the United States. Around 40% of American ladies are determined to have a no dermatological development among their period, and breast tumor is second just to lung disease as a cause for malignancy-related mortality amongst women. The cervical disease is the tenth most regular tumor among ladies and records for right around 2% of female malignancy passing. The American Cancer Society expects that about 40200 women will have kicked the bucket from breast growth and 4400 will have passed on from the cervical illness in the year 2001.

Mammography and Papanicolaou (Pap) tests are important parts of early detection and treatment, and death rates are significantly reduced when breast and cervical tumors are identified and treated at a beginning time.

Track 6: Male Breast Cancer

Breast cancer in men could be a rare illness. but about 1% of whole breast cancers arise in men. Men, and women, girls and boys altogether have breast tissues. the varied hormones in girls' and women's bodies stimulate the breast tissue to grow into full breasts. Boys' and men's bodies commonly do not build a lot of the breast-stimulating hormones. As a result, their breast tissue typically stays flat and small. however generally men will develop real breast secretory organ tissue as a result of they take bound medicines or have abnormal secretion levels. Breast and Cervical Malignancy Congress incorporates the exchange on future elements of male and feminine breast illness. In 2017, about 2,470 men are expected to be diagnosed with the illness. For men, the period risk of being diagnosed with carcinoma is regarding 1 in 1000.

Track 7: Breast Reconstruction (Oncoplastic Surgery)

Breast-conservation surgery (BCS) is set up as a comfortable alternate for most ladies with early breast illness. As of late, propels in Oncoplastic procedures have diminished surgical injury and along these lines are equipped for protecting the breast shape and personal fulfilment. Notwithstanding the most BCS abnormalities can be made do with the essential conclusion, the stylish result might be unaware. Oncoplastic reproduction may start at the season of BCS (quick), weeks (deferred prompt) or months to years subsequently (postponed). With quick remaking, the surgical procedure is smooth, since the two approaches can be related to one agent setting. Furthermore, it licenses more wide extraction of the tumor, with a major mean volume of the example and possibly reducing the rate of edge association. The Oncoplastic strategies are known with volume subtraction or substitution methods with closer folds, latissimus dorsi myocutaneous fold, and degeneration mammoplasty/mastopexy. Breast and Cervical Cancer Conferences is an unmistakable stage to unite worldwide predictable scholastics in the field of tumor treatments. Maximum breast reconstructions achieved today are immediate reconstructions with implants.

Track 8: Breastfeeding and Breast Cancer

Breastfeeding is a complex yet important responsibility for some mothers since it might be painful for the reliability of both baby and mother. Studies determine that even irrelevant breastfeeding reduces a lady's danger of breast cancer by around 30 percent. This has even seemed in ladies with a BRCA1 mutation, which builds the risk for breast growth. On the off chance that a patient is determined to have breast cancer while nursing, most doctors will advise that they quit breastfeeding. Frequent treatments utilized among breast malignancy treatment might be passed to the infant through breast milk, with chemotherapies, hormone treatments and anaesthesia managed amid surgery. Stopping breastfeeding will similarly reduce blood flow to the breasts, making them smaller, less difficult to look at and more averse to wind up simply contaminated.

Track 9: Chemotherapy and Cancer

Chemotherapy is a cancer treatment that makes use of tablets to stop the boom of most cancers’ cells, both by way of killing the cells or through preventing them from dividing. When chemotherapy is taken by orally or vaccinated into a vein or muscle, the drug enters the bloodstream and may spread most cancers cells in the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body deep space with the abdomen, the drugs affect most cancers cells in those areas (nearby chemotherapy). Breast and Cervical Cancer Conference has given superb breast and cervical growth screening measures and varied technique of medications. The manner the chemotherapy is given depends on the type and degree of the most cancers being handled. Systemic chemotherapy is used in the medicine of breast utmost cancers.

Track 10: Molecular Oncology in Breast Cancer

In the present period, sub-atomic oncology has cleared its way in the systematic cancer care and is affected a life-threatening part, particularly in the discovery of novel cell, focuses to misuse for novel focused on medications, new biomarkers unique proof for primary malignancy location, and to give a greater characterization of tumors for guess and treatment choice. The sub-atomic premise of breast carcinogenesis with hereditary and epigenetic occasions that result in the transformed articulation of several qualities is yet not completely known and still should be interpreted more, which mirrors the unpredictability of the sub-atomic changes that portray tumor cells.

The major of the breast malignancy genome is specifically subdued; around, 3-5% of abilities are dynamic in a specific tumor cell that is administered by the route of quality articulation, for the most part at the level of transformation. Cell bother (change) causes variations in quality articulation that outcome in the declaration of various quality items and the suppression of others. Consequently, sub-atomic heterogeneity is created that defines tumor of various histology and adds to the variability in result and reaction to treatment. Further, huge variability additionally happens for tumors of a histologic write. Till as of late, in breast disease management, clinical choices, visualizations, and expectations were made exclusively upon histopathologic investigation, or one or little amounts of qualities or their appearances (proteins) in the tumor tissue, yet this approach has been lacking and neglected to create exact conclusions. There has been an increase in the new worldview called "Genomic Paradigm," a move from the seniority "Clinico-Pathological Paradigm".

Track 11: â€‹Cancer Epigenomics: Beyond Genomics

Cancer epigenetics is the examination of epigenetic changes to the genome of tumor cells that don't contain an adjustment in the nucleotide sequence. Epigenetic alterations are as serious as hereditary changes behind the growth of a cell from normal to malignant, and their control holds awesome guarantee for disease remedial action, detection and treatment. In various types of growth, an assortment of epigenetic systems can be irritated, for example, hushing of tumor silencer abilities and initiation of oncogenes by familiar CpG island methylation designs, histone variations and dysregulation of DNA restricting protein.

DNA methylation variations in disease cells include the loss of methylation at frequently methylated arrangements (hypo-methylation) and the pickup of methylated sequences at locales normally un-methylated (hyper-methylation). Growth Epigenomics comprises the examination of epigenetic variations in malignancy and can be disordered by inquiries of conditions and end results.

Track 12: HPV and Pregnancy

HPV is possibly not going to effect pregnancy or child's wellbeing. On the off chance that you have genital warts, they may develop quicker amid pregnancy, possibly from the additional vaginal release that gives the infection a clammy developing condition, hormonal changes, or variations in your immune system. Much of the time, warts won't characterize any issues for the patient or her infant. It's workable for you to pass the contamination to your child, yet this doesn't occur all the time. Regardless of whether your youngster contracts HPV, he's possibly going to defeat it all alone with no side effects or issues. In the far-fetched occasion that your youngster gets the kind of HPV that causes genital warts, he may produce warts on his vocal strings and changed territories at some point in outset or adolescence. This condition, called repetitive papillomatosis, is intense, yet luckily it's additionally uncommon.

Track 13: Nanotechnology / Nanomedicines in Cancer Treatment

The use of nanotechnology in growing treatment offers some stimulating potential outcomes, with the likelihood of destroying malignancy tumors with insignificant harm to sound tissue and organs, and furthermore the discovery and removal of diseased cells before they frame tumors. One treatment being worked on contains focused on chemotherapy that carries a tumor-executing specialist called tumor rot factor alpha (TNF) to rising tumors. TNF is connected to a gold nanoparticle along with Thiol-derivatized polyethylene glycol (PEG-THIOL), which secretes the TNF bearing nanoparticle from the safe framework. This permits the nanoparticle to sequence through the circulatory system without being attacked.

Track 14: Cancer Vaccination

Certain sorts of chemotherapy and radiation treatment can weaken the safe framework, hitting malignancy patients at expanded hazard forever undermining diseases. Along these lines, frequent tumor patients may need to get revaccinated in contrast to illnesses they got immunizations for as youngsters. Antibodies need a sound insusceptible framework that is ready to observe and execute illness-causing germs. Furthermore, it takes a sound insusceptible framework no less than 2 weeks from the season of immunization to begin observing and removing germs. That implies immunization timing is similarly as important as getting the vaccination itself. When all is said in done, vaccinations isn’t given amid chemotherapy or radiation treatment.

Track 15: Women’s Health and Contraception

Developments in the discovery and management of disease have expanded personal satisfaction for patients with malignancy both within and after treatment. Numerous malignancy patients are seeing somebody where sexual measure a piece of their lives is. Exposed intercourse can bring about pregnancy nevertheless when the prospect of productivity is regarded as insignificant. Pregnancy might be undesired as a effect of the potential teratogenic influences of disease medications, or terror that the pregnancy will adversely affect the course of the growth. Breast and Cervical Cancer Conference has given superb breast and cervical growing transmission procedures and various methods of medications. Ladies facing malignancy treatment and female tumor fighters will possibly end a pregnancy, an activity that has mental and avid results. Accordingly, it is vital to give fitting advising about contraception to these ladies.

Track 16:  Cancer Therapeutics

The characteristic treatment modalities are correlated to serious symptoms and high harmfulness which thusly swift low personal satisfaction. This assessment encloses novel systems for more powerful chemotherapeutic transmission forecasting to create better anticipation. Right now, tumor treatment is a intensely unique field and enormous advances are being made in the development of novel progress treatment procedures. As opposed to usual malignancy therapeutics, novel procedures, for example, ligand or receptor-based concentrating on, intracellular medication focusing on, excellence conveyance, tumor identical organism treatment, attractive medication focusing on and ultrasound-interceded demure conveyance, have comprised new modalities for growth treatment. 

Track 17: Gynecologic Oncology

Gynaecologic Oncology is a field of drug that focuses on malignancies of the female conceptive framework, with ovarian disease, uterine cancer, vaginal tumor, cervical disease, and Vulvar malignancy. In Oncology Meeting 2019, speakers will talk about the important focuses with respect to immunotherapy, Immune checkpoint inhibitors to treat illness, and related researches of tumor inoculation. As establishments, they have broad preparing in the purpose and treatment of these tumors.

Track 18: Complementary and Alternative Medicine for cancer

The natural resolution develops plants, or a blend of plant separates, to treat illness and advance well-being. The two most standard composes applied as a part of the UK are Western and Chinese home-grown pharmaceutical. Home-grown drug aims to re-establish your body's capacity to protect, direct and recover itself. It is a whole-body approach that takes a glance at your physical, mental and excited prosperity. It is at times called Phyto-medicine, Phyto-therapy or organic solution. Numerous cutting-edge drugs are formed with plants. However, botanists don't distinct plant materials in the way the medication business does. In Breast and Cervical, Malignancy meetings will likewise talk about several methods to avoid growth and interrelated infections. The two most normal sorts of usual medication used as a part of the UK are Western and Chinese home-grown pharmaceutical. Less basic comprises include Tibetan or Ayurveda medication (Indian).

Track 19: Cancer Biomarkers

Biomarkers are elements that show characteristic or strange procedures occurring in your body and might be a sign of a secreted condition or ailment. Different classes of molecule, for example, DNA (genes), proteins or hormones, can be assists as biomarkers since they all determine something about your Health. Biomarkers might be formed by the cancer tissue itself or by various cells in the body in response of cancer. They can initiate in the blood, stool, pee, tumor tissue, or various tissues or organic liquids. Remarkably, biomarkers are not inadequate to cancer. There are biomarkers for heart disease, multiple sclerosis, and several other sicknesses.

A Cancer biomarker outlines as a substance or development that is indicating the presence of cancer in the body. A biomarker might be a molecule released by a tumor or a response of the body to the presence of cancer. Hereditary, epigenetic, proteomic, glycomic and imaging biomarkers can be applied for cancer analysis, visualization, discovery, and the study of disease transmission. Ideally, such biomarkers can be restrained in non-invasively composed bio-fluids like blood or serum.

BRECECAN 2019 invites participants, moderators, and exhibitors from everywhere throughout the world to Amsterdam, Netherlands. We are charmed to welcome all of you to go to and enlist for the '' 4th World Conference on Breast and Cervical Cancer '' which will be held on November 14-15, 2019 in Amsterdam, Netherlands. The sorting out advisory group is preparing for an energizing and instructive gathering program including entire addresses, symposia, workshops on an assortment of subjects, notice introductions and different projects for members from everywhere throughout the world. We welcome you to go along with us at the BreCeCan-2019, where you will make certain to have an important involvement with researchers from around the globe. All individuals from the BRECECAN 2019 arranging board anticipate meeting you in Amsterdam, Netherlands.

IMPORTANCE AND SCOPE:

BRECECAN 2019 offers with Breast most cancers expertise and traits, Screening, Detecting and Diagnosing Breast most cancers, Breast most cancers therapy, inhibition and medicinal drug, surgical procedure choices for Breast most cancers, Modified medicine, medical trials of Breast most cancers, Male Breast cancer, Cancer Biomarkers and Breast Cancer Nursing. Breast most cancers is the main kind of cancer from which most of the ladies are struggling international. Cognizance almost the breast most cancers risks, signs and symptoms and treatment could be life-threatening. Advent of latest strategies within the area of drugs in addition to prognosis is going on worldwide. BRECECAN 2019 offer a platform for sharing of facts approximately the breast most cancers remedy techniques and newly advanced strategies for the same as nicely as offer platform approximately the latest researches on breast most cancers. This occasion includes activate keynote presentations, oral talks, poster presentations and exhibitions.

In line with world Health Organization (WHO) in 2012, round 521,000 people died due to breast most cancers and this variety is predicted to growth within the near destiny. Like various metastatic cancers, surgical removal of metastatic breast cancer is considered useless and frequently effects in higher threat of loss of life (80% - 90% of the recognized population). Prognosis is usually based at the stage of breast most cancers within the patient; this staging is carried out by using the same old TNM staging technique, wherein T stands for tumor, N stands for node swelling, accompanied through TNM i.e. the metastatic stage of the most cancers. Those manifestations are utilized inside the class of metastatic breast most diseases into 4 levels, levels 1-three involves moderate spread of carcinoma from various areas of the breast. But doesn’t contain metastasis; degree 4 shows a full-blown metastasis which indicates involvement of lymph nodes near or remote from the breasts and spread to different organs consisting of bones, lung and the mind.

Cervical cancer is the second maximum usually conventional cancer and the 1/3 greatest cause of loss of life in girls, with 530,000 new instances discovered each 12 month the global cervical most cancers diagnostics exams marketplace is segmented through take a look at kinds into Pap smear exams, colposcopy, HPV checking out, Endo-Cervical Curettage (ECC) procedure and others, which incorporates cone biopsy and loop electrosurgical excision procedure (LEEP). The Pap slight tests section is also forecast to progress at a CAGR of extra than 6% during the forecast period from 2014 to 2020 North America become the major marketplace for cervical cancer analytical tests in 2013. The global cervical cancer diagnostic checks market has been segmented into 4 principals nearby markets: North America, Europe, Asia Pacific and relaxation of global. The marketplace length estimates and forecasts for the length 2012 to 2020 were well-found for each of those areas at a phase stage, in terms of USD million at the side of the CAGR for the prediction period 2014 to 2020. Aspects which have lacking the market in North the USA are rising occurrence of cervical most cancers cases, fast technological enhancements, and emerging attention approximately malignant significances of cervical most cancers among people. Further, diverse reimbursement rules associated with the remedy of cervical most cancers could most possibly gas the increase of the market within the next few years. However, Asia Pacific is projected to witness the highest boom fee over the forecast period from 2014 to 2020.

Figure 1: Breast Cancer: Estimated age-standardized rates worldwide according to Age groups.

Figure 2: Cervical Cancer: Estimated age-standardized rates worldwide according to Age groups.

• Estimated number of new cases of breast cancer diagnosed in 2017:

           17,730 =    144 males +    17,586 females

• Estimated % of all new cancer cases diagnosed in 2017 = 13%
• Estimated number of deaths from breast cancer in 2017:

           3,114 =    28 males +     3,087 females

• Estimated % of all deaths from cancer in 2017 = 6.5%
• Chance of surviving at least 5 years (2009–2013) = 90%

WHY AMSTERDAM?

Amsterdam, capital of the Netherlands! It is in the province ‘Noord-Holland’, situated in the west and one of the most popular destinations in Europe, receiving more than 4.5 million tourists annually. Amsterdam is headquartering many large Dutch institutions with a base to seven out of World’s 500 largest companies such as Philips, ING, Uber, Netflix, and Tesla. Amsterdam is unique for its large and untouched historic Centre with a rich architectural history, dominated by water. It is a meeting point for all different cultures around the world and has a welcoming attitude towards visitors. It also bagged 12^th position worldwide in terms of quality living environment & infrastructure stated by one research group.

Amsterdam is well known for its museums, red light district, coffee shops but also the great variety of eating & drinking places and night life. It is the world’s most multinational cities representing about 177 nationalities which define its unity in diversity motto. It even privileges to be the ‘Gay capital of Europe’. Therefore several hotels and hostels can be found on different locations, value for money and environment. Amsterdam is well associated with Metro services, tram, train, bus and Airport with other cities in Europe as well as major cities of the world. Amsterdam Airport Schiphol is the main International Airport and is less than 20 minutes far from the city central station. Amsterdam is listed under most bicycle-friendly cities in the World.

RELATED CONFERENCE

• 8^th World Conference on Women’s Health and Breast Cancer, December 17-18, 2018 Abu Dhabi, UAE
   
• 30th Experts Meet On Cancer Therapy, November 14-15, 2018 Melbourne, Australia
   
• 2nd International Conference on Cancer Genetics and Epigenetics, November 12-13, 2018 Tokyo, Japan
   
• 2nd Global Meeting on Clinical Oncology & Radiology, Mar 27-28, 2019 Hong Kong.
   
• 5th International Congress on Epigenetics & Chromatin, August 22-23, 2019 Vienna, Austria.
   
• 26th Cancer Genomics Congress: New Era for Cancer Prevention, October 21-22, 2019 Abu Dhabi, UAE
   
• International Conference on Biomarkers and Cancer Targets, November 18-19, 2019 Dubai, UAE
   
• 27th World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology, December 07-08, 2018 Chicago, Illinois, USA
   
• 13th World Biomarkers Congress, November 29-30, 2018 Dublin, Ireland
   

RELATED SOCIETIES:

EUROPE:

European Society of Oncology Pharmacy; European Society of Surgical Oncology; Organization of European Cancer Institutes; Union for International Cancer Control; Universal Medical Centre; Society of Nuclear Medicine and Molecular Imaging; European Society of Gynaecological Oncology; French Endocrine Society; German Society of ORL HNS; Association, International Association of Endocrine Surgeons; International Federation of Oto-Rhino-Laryngological Societies; International Thyroid Oncology Group; Society of Nuclear Medicine and Molecular Imaging; European Association of Urology; European Society For Medical Oncology; Rational Therapy for Breast Cancer; European Laryngological Society; European Society of Endocrinology; French Endocrine Society; European Society of Skin Cancer Prevention; Society of Nuclear Medicine and Molecular Imaging; European Oncology Nursing Society; European Organization for Research and Treatment of Cancer; Dutch Endocrine Society; Association of European Cancer Leagues; EAU Section of Oncological Urology; European Academy of Cancer Sciences; European Association for Cancer Research, European Association for Neuro-Oncology; European Organization for Research and Treatment of Cancer; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; European Organisation for Treatment of Trophoblastic Disease; European Breast Cancer Coalition EUROPA DONNA; European Cancer Organization; European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer; European School of Oncology; European Society for Medical Oncology; European Society for Therapeutic Radiation and Oncology; European Society of Breast Cancer Specialists; European Society of Gynaecological Oncology; European Society of Oncology Pharmacy; European Society of Breast Cancer Specialists; European Society of Gynaecological Oncology; European Society of Paediatric Oncology; European Society of Skin Cancer Prevention; European Society of Surgical Oncology; Mediterranean Oncology Society; Organization of European Cancer Institutes; European Research Organization on Genital Infection and Neoplasia; European Group for Blood and Marrow Transplantation; European Society of Breast Cancer Specialists; European Network of Cancer Registries; European Cancer Organisation; European Oncology Nursing Society.

USA:

Acoustic Neuroma Association; American Association for Cancer Research; American Bone Marrow Donor Registry; American Brain Tumor Association; American Cancer Society; American Childhood Cancer Organization Society for Immunotherapy of Cancer Radiation Therapy; Oncology Group Prevent Cancer Foundation; Pancreatic Cancer Action Network; Oncology Nursing Society; Onco-fertility Consortium; Ocular Melanoma Foundation; National Lung Cancer Partnership; National Familial Pancreas; Tumor Registry National Familial Lung Cancer Registry; National Council on Skin Cancer Prevention; National CML Society National Children's Leukaemia Foundation; National Cancer Registrars Association; National Brain Tumor Society; Musculoskeletal Tumor Society; Melanoma Research Foundation Lymphoma Research Foundation; Lung Cancer Foundation of America Haematology/Oncology Pharmacy Association; Foundation for Women's Cancer, Society for Neuro-Oncology, Society for Radiation Oncology Administrators; Society of Surgical Oncology, Society of Gynaecologic Oncology; Society of Gynaecologic Nurse Oncologists;  Southwest Oncology Group American Association of Endocrine Surgeons; American Association of Clinical Endocrinologists; American Head and Neck Society; American Thyroid Association; Association of Women Surgeons; Canadian  Association of Pathologists; Canadian Society of Otolaringology – Head and Neck Surgery; Latin American Cancer Society.

ASIA PACIFIC AND MIDDLE EAST

The National Asian Breast Cancer Initiative, Asian Clinical Oncology Society; Childhood Cancer International; World Cancer Research Fund International; Asia-Pacific Society of Thyroid Surgery; Brazilian Society of Head and Neck Surgery; Korean Society for Head and Neck Oncology; Korean Society of Thyroid-Head and Neck Surgery; Korean Society of Otorhinolaryngology-Head and Neck Surgery; The Israel Society of Head and Neck Surgery and Oncology ; Asia-Pacific Cancer Society ; Asian Health Coalition; Asian Breast Cancer Society, Asia-Pacific Cancer Society; Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asia-Pacific Society of Thyroid Surgery; Brazilian Society of Head and Neck Surgery; Asia-Pacific Cancer Society ; Asian Health Coalition; Asian Breast Cancer Society; Association of Oncologists of Uzbekistan; Chinese Society of Clinical Oncology (CSCO); Hong Kong Cancer Therapy Society; Indian Society of Medical & Paediatric Oncology (ISMPO); Indonesian Society of Haematology and Medical Oncology (ISHMO); Iranian Cancer Association (ICA); Iranian Society of Clinical Oncology (ISCO); Iranian Society of Medical Oncology and Haematology (ISMOH); Japan Society of Clinical Oncology (JSCO); Japanese Society of Medical Oncology (JSMO); Korean Association for Clinical Oncology (KACO); Malaysian Oncological Society; Medical Oncology Group of Australia (MOGA); Myanmar Oncology Society; New Zealand Society for Oncology (NZSO); Oncology Club, Bangladesh; Pakistan Society of Clinical Oncology (PSCO); Philippine Society of Medical Oncology (PSMO); Singapore Society of Oncology (SSO); Taiwan Oncology Society (TOS); Thai Society of Clinical Oncology (TSCO); Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asian and Oceania Thyroid Association; Asia-Pacific Society of Thyroid Surgery; The Japan Endocrine Society; The Japan Thyroid Association; Foundation for Head and Neck Oncology;  Israel Endocrine Society; Asian Breast Cancer Society; Asian Health Coalition; Asian Cancer Foundation ; Asian Pacific Prostate Society; Asia-Pacific Cancer Society; Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asian and Oceania Thyroid Association; Asia-Pacific Society of Thyroid Surgery.